Newsfeeds - Spark Newswire

1 minute read

Citigroup Initiates Coverage On 9 Meters Biopharma with Neutral Rating, Announces Price Target of $2.7

Today, 5:11 PM

Citigroup analyst Samantha Semenkow initiates coverage on 9 Meters Biopharma (NASDAQ:NMTR) with a Neutral rating and announces Price Target of $2.7.

NMTR

3 minute read

Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 5:11 PM

Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.

ALLR

17 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 5:11 PM

During Friday's trading, 293 companies set new 52-week lows.

ACEL

14 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 5:11 PM

On Thursday, 241 companies hit new 52-week lows.

ACHL

1 minute read

9 Meters Biopharma Announces Continued Immuno-Oncology Collaboration With Gustave Roussy

By Benzinga Newsdesk

Today, 5:11 PM

Collaboration focuses on the relationship between intestinal microbiome composition and systemic responses to cancer treatments and builds upon additional positive preclinical data with investigational agent

NMTR

23 minute read

News
Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 5:11 PM

On Monday, 413 companies reached new 52-week lows.

AAN

2 minute read

9 Meters Biopharma Presents Preclinical Data On Glucose-Dependent Insulinotropic Polypeptide Monoclonal Antibodies For Obesity At The American College Of Gastroenterology 2022 Annual Scientific Meeting October 21-26

By Benzinga Newsdesk

Today, 5:11 PM

Preclinical data investigated the use of glucose-dependent insulinotropic polypeptide (GIP) monoclonal antibodies (mAbs) to prevent and treat obesity in animal models Poster granted Outstanding Research Award 9

NMTR